Dr. Chovatiya discusses the effectiveness of providing a moisturizer in combination with a topical or systemic therapy to achieve clear skin regardless of disease severity.
Andrew Mastro discusses various challenges of treating AD in the head-and-neck area, emphasizing the importance in choosing a treatment armed with rapidity, power, and a...
PLAY
Naiem T. Issa, MD, PhD: Mitigating Economic Impacts of Atopic Dermatitis through Effective Treatment
Dr. Issa discusses a real-world study¹ that demonstrated a reduced need for biologic treatments, among other AD treatments, in patients treated with topical ruxolitinib cream,...
PLAY
Dr. Dasilva discusses positive results from a recent study published in the Journal of Clinical and Aesthetic Dermatology that assessed the safety and efficacy of...
PLAY
Lisa Swanson, MD, JCAD’s Section Editor of Pediatric Dermatology, shares her thoughts on new research evaluating maximum-use conditions for topical ruxolitinib cream in pediatric patients...
PLAY
Michael Cameron, MD, FAAD: Improving Itch and Quality of Life in Patients with Atopic Dermatitis
Dr. Cameron discusses promising results in a treatment that combined upadacitinib and topical corticosteroids. Reference:
PLAY
James Song, MD: Personalizing Treatment for Atopic Dermatitis
Looking to the future of AD treatment, Dr. Song discusses the unmet need of predicting treatment responses in patients with atopic dermatitis, with the aim...
PLAY
Melodie Young, MSN, RN, ANP-C: Treating Pediatric Patients with Atopic Dermatitis
Melodie Young discusses managing treatment for younger children with atopic dermatitis, emphasizing the importance of focusing on potential and probable side effects with their caregivers.
PLAY
James Song, MD, FAAD: Checking in on Long-term Safety Data on JAK Inhibitors for Atopic Dermatitis
Dr. Song discusses the latest safety data on topical and oral JAK inhibitors for patients with atopic dermatitis.
PLAY
James Del Rosso, DO: Evaluating Effective Topical Therapies for Atopic Dermatitis
Dr. Del Rosso discusses the current topical treatments available for patients with atopic dermatitis that have shown consistent efficacy with limited adverse events.
PLAY